Louisiana State Employees Retirement System’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
IA
VCM
VAM
Louisiana State Employees Retirement System's AZN Position: Q1 2026 in Review
Louisiana State Employees Retirement System sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 19,500 shares — an estimated $3.59M sold.
Louisiana State Employees Retirement System first reported a position in AZN in Q1 2022 and held it in 16 quarters. The position peaked at $3.61M in Q2 2024. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Louisiana State Employees Retirement System reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
- Louisiana State Employees Retirement System sold 19,500 AstraZeneca shares in Q1 2026, an estimated $3.59M.
- Louisiana State Employees Retirement System first reported a position in AstraZeneca in Q1 2022 and held it in 16 quarters.
- Louisiana State Employees Retirement System's AstraZeneca position peaked at $3.61M in Q2 2024.
- 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Louisiana State Employees Retirement System's 13F filing for Q1 2026, filed 20 Apr 2026.